Search clinical trials for: tumors

Total 15869 results

University Medical Center Groningen

Terminated

Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors

High-Risk Breast Cancer

Netherlands
Adnexus, A Bristol-Myers Squibb R&D Company

Completed

CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma

Cancer

United States
Anza Therapeutics, Inc.

Terminated

Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment

Carcinoma, Non-Small-Cell Lung | Adenocarcinoma of the Pancreas | Malignant Epithelial Mesothelioma | Adenocarcinoma of the Ovaries

Israel, United States
Radboud University Medical Center
Dutch Cancer Society

Completed

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients

Melanoma
Radboud University Medical Center
Dutch Cancer Society

Completed

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

Melanoma Stage III or IV

Netherlands
Ludwig-Maximilians - University of Munich

Unknown

Prevention of Liver Damage During Liver Surgery (LTR)

Liver Tumors
Hadassah Medical Organization

Unknown

Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors

Neuroendocrine Tumor

Israel
University Health Network, Toronto
Novartis; Mount Sinai Hospital, Canada; Princess Margaret Hospital, Canada

Terminated

Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib (GIST)

Chronic Myeloid Leukemia | Chromosome Abnormality | Gastrointestinal Stromal Cell Tumors

Canada
St. Jude Children's Research Hospital
University of Miami

Completed

Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas

Neuroblastoma | Central Nervous System Tumors | Wilms Tumor | Lymphomas

United States
Pfizer

Completed

CPG 7909 Injection in Melanoma

Carcinoma, Melanoma
European Organisation for Research and Treatment...

Unknown

Vaccine Therapy in Treating Patients With Primary Stage II Melanoma

Melanoma (Skin)

Italy, France, Spain, Switzerland, United Kingdom, Belgium, Australia, Norway, Poland, Finland, Netherlands, Germany, Israel, Denmark, Serbia, Estonia, Portugal, Russian Federation
National Cancer Institute (NCI)

Completed

Carmustine in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)

Completed

Brachytherapy in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)

Completed

O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Weill Medical College of Cornell University

Suspended

Biological Therapy in Treating Patients With Primary or Advanced Glioma

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)

Completed

Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors

Brain and Central Nervous System Tumors
National Cancer Institute (NCI)

Completed

Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Peregrine Pharmaceuticals

Completed

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)

Completed

Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain

Brain and Central Nervous System Tumors

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Unknown

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Northern California Melanoma Center
Pfizer; Schering-Plough

Terminated

Temodar and Sutent as Therapy for Melanoma

Metastatic Malignant Melanoma

United States
Rutgers University

Unknown

Study Investigating MEN1 and SDHD in Familial Carcinoid Tumors

Carcinoid Neuroendocrine Cancer

United States
Eisai Inc.

Suspended

A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid Tumors

Cancer

United States
Siemens Molecular Imaging

Completed

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 (K5)

Melanoma | Sarcoma | Breast Cancer | Lung Cancer | High Grade Gliomas

United States
MedImmune LLC

Completed

Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors

Cancer

France
Children's Medical Center Dallas
Metabolic Solutions Inc.; Simmons Cancer Center

Completed

A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors

Solid Tumors

United States
Boneca Corporation

Completed

BNCT to Treat Glioma That Has Progressed Following Radiotherapy

Glioblastoma | Anaplastic Astrocytoma

Finland
NicOx

Completed

A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function (HCT3012-X-106)

Renal Failure

United States
SCRI Development Innovations, LLC
GlaxoSmithKline; Genentech, Inc.

Completed

Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors

Cancer
H. Lee Moffitt Cancer Center and Research Institute
Schering-Plough

Terminated

Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma

Glioblastoma | Gliosarcoma

United States
Bristol-Myers Squibb

Completed

A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)

Tumors

United States
OSI Pharmaceuticals

Completed

Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors

Advanced Solid Tumors

United States
AstraZeneca

Completed

Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors

Advanced Solid Metastatic Tumor

United Kingdom
Helsinn Healthcare SA

Terminated

XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

Biliary Tract Cancer

United States, Spain, Canada, France, Germany, Hungary, Italy, Belgium, Poland, Russian Federation, United Kingdom
National Cancer Institute (NCI)

Completed

Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)

Completed

Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
PharmaNet
Celtic Pharma Development Services

Terminated

Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)

Peritumoral Brain Edema | PRIMARY MALIGNANT and METASTATIC BRAIN TUMORS
Bristol-Myers Squibb

Completed

A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors

Neoplasms

United States
Xenova Biomedix

Withdrawn

Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme

Glioblastoma Multiforme

United States, Australia
MediGene
National Cancer Institute (NCI)

Completed

G207 Followed by Radiation Therapy in Malignant Glioma

Malignant Glioma

United States
Adherex Technologies, Inc.

Terminated

A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

Hepatocellular Carcinoma

Taiwan, Singapore, United States
Adherex Technologies, Inc.

Suspended

A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors

Neoplasms

United States
Rigshospitalet, Denmark
Odense University Hospital; Aalborg University Hospital

Completed

Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas

Malignant Gliomas

Denmark
CASI Pharmaceuticals, Inc.

Completed

Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma

Recurrent Glioblastoma Multiforme

United States
Synta Pharmaceuticals Corp.

Completed

STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors

Lymphoma | Leukemia | Hematological Malignancies | Metastatic or Unresectable Solid Tumors

United States
CASI Pharmaceuticals, Inc.

Completed

Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)

Recurrent Glioblastoma Multiforme

United States
Samsung Medical Center

Completed

Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

Mycoses | Brain Tumor | Neuroblastoma | Retinoblastoma | Wilms Tumor

Korea, Republic of
Pfizer

Completed

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Non Small Cell Lung Cancer | Advanced Solid Tumors

United States
Bristol-Myers Squibb

Completed

MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors

Neoplasm Metastasis | Tumors

Italy, United Kingdom, United States, Canada

Search clinical trials for: tumors

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations